✦ LIBER ✦

Bortezomib, doxorubicin, and dexamethasone combination therapy followed by thalidomide and dexamethasone consolidation as a salvage treatment for relapsed or refractory multiple myeloma: analysis of efficacy and safety

✍ Scribed by Sung Sook Lee; Cheolwon Suh; Bong-Seog Kim; Jooseop Chung; Young-Don Joo; Hun-Mo Ryoo; Young Rok Do; Jong-Youl Jin; Hye Jin Kang; Gyeong-Won Lee; Moon Hee Lee; Hyeok Shim; Kihyun Kim; Sung-Soo Yoon; Soo Mee Bang; Ho Young Kim; Je-Jung Lee; Jinny Park; Dong Soon Lee; Jae-Hoon Lee; the Korean Multiple Myeloma Working Party (KMMWP)

Publisher: Springer
Year: 2010
Tongue: English
Weight: 151 KB
Volume: 89
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-010-0943-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sequential vincristine, adriamycin, dexa

Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial

✍ Hye Jin Kim; Sung-Soo Yoon; Dong Soon Lee; Sang Kyun Sohn; Hyeon Seok Eom; Jung 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 184 KB